Shopping Cart
- Remove All
- Your shopping cart is currently empty
RIP2 Kinase Inhibitor 4 is a highly potent and selective RIPK2 PROTAC compound that efficiently degrades RIPK2 (pIC50 value of 8) and effectively inhibits the release of TNF-α.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | Inquiry | Backorder |
Description | RIP2 Kinase Inhibitor 4 is a highly potent and selective RIPK2 PROTAC compound that efficiently degrades RIPK2 (pIC50 value of 8) and effectively inhibits the release of TNF-α. |
In vitro | RIP2 Kinase Inhibitor 4 (Compound 20) is a novel inhibitor targeting the apoptosis (IAP) binder, with reduced binding to the cIAP1 and XIAP BIR3 domains but enhanced binding to the XIAP BIR2 domain[1]. Additionally, it recruits IAP E3 ligases and significantly reduces MDP-induced TNFα production in human PBMCs, with a pIC50 value of 9.3[1]. |
In vivo | The initial in vivo evaluation of RIP2 Kinase Inhibitor 4 (Compound 20) in rats, administered subcutaneously at a dose of 0.5 mg/kg, showed significant degradation of RIPK2 and suppression of MDP-induced TNFα release after 48 hours[1]. |
Molecular Weight | 1045.23 |
Formula | C50H66F2N14O7S |
Cas No. | 2126803-41-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.